This report reviews the differences in the prices of pharmaceuticals among EU member states. It reviews the approaches that member states have used to regulate the pharmaceutical market on both the supply and demand sides, and assesses evidence regarding the impact of these different approaches on pharmaceutical prices, cost containment and industry innovation. The report considers policy options to strengthen coordination among member states and exchange best practice.